List of precautions when using budesonide extended-release capsules

Budesonide extended-release capsules, as a prescription corticosteroid drug specifically for the treatment of mild to moderate Crohn's disease, are specially designed for patients 8 years old and above with lesions involving the small intestine (ileum) and part of the large intestine (ascending colon), and can effectively prevent the recurrence of symptoms in adult patients for up to 3 months. However, this drug is very powerful and requires patients and medical professionals to pay attention to a series of key precautions when using it.

Before starting treatment with budesonide extended-release capsules, patients must fully disclose their allergy history to their healthcare provider, especially any allergic reactions to any component of the drug, as severe allergic reactions can be life-threatening. At the same time, the patient's overall health status must also be fully disclosed, including but not limited to liver disease, upcoming surgery, exposure to infectious diseases such as chickenpox or measles, infectious status, chronic diseases such as diabetes or glaucoma, cataracts, past history of tuberculosis, high blood pressure, reduced bone density (such as osteoporosis), gastric ulcers, and plans for pregnancy or breastfeeding.

We are particularly vigilant that budesonide extended-release capsules may cause potential harm to the fetus, so pregnant women or women trying to become pregnant should avoid using them. If you become pregnant or suspect you are pregnant during treatment, you should notify your healthcare provider immediately. Likewise, women who are breastfeeding or planning to breastfeed should consult their doctor, as it is unknown whether the drug is passed to the baby through breast milk.

During medication, patients are also required to list in detail all medications they are taking, including prescription drugs, over-the-counter drugs, vitamins and herbal supplements, because budesonide extended-release capsules may interact with certain drugs and cause side effects. In addition, drinking grapefruit juice should be avoided as it may increase drug concentration in the blood and affect its efficacy.

Budesonide extended-release capsules may cause side effects such as headache, nausea, and abdominal pain. Once any discomfort occurs, patients should seek medical advice immediately and inform medical staff. To ensure that the medicine is stable and effective, it should be stored at room temperature between 68°F and 77°F (20°C and 25°C) and the container should be kept tightly closed.

In summary, budesonide sustained-release capsules are an effective drug for the treatment of mild to moderate Crohn's disease, but their use must strictly follow medical instructions and precautions. Patients should fully understand their health status and potential risks of drugs, maintain close communication with medical staff, and jointly develop personalized treatment plans. At the same time, correct medication use and proper storage are also keys to ensuring the safety and effectiveness of medications.

Reference: https://www.drugs.com/pro/entocort-ec.html#s-34090-1